Assignee
GC GENOME CORP
KR·3 granted patents·11 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
14 records- 0165US2026045360A1Method for diagnosing cancer and predicting cancer type by using terminal sequence motif frequency and size of cell-free nucleic acid fragmentGC GENOME CORP·Filed 2025·Application pending·0 cites
- 0265US2024417813A1Artificial-intelligence-based cancer diagnosis and cancer type prediction methodGC GENOME CORP·Filed 2024·Application pending·0 cites
- 0355US12374462B2Method for diagnosing cancer and predicting cancer type by using terminal sequence motif frequency and size of cell-free nucleic acid fragmentGC GENOME CORP·Filed 2023·Granted Jul 29, 2025·0 cites·16 claims
- 0455US12163194B2Artificial-intelligence-based cancer diagnosis and cancer type prediction methodGC GENOME CORP·Filed 2021·Granted Dec 10, 2024·0 cites·12 claims
- 0555US2025391563A1Method for diagnosing and predicting cancer type using methylated cell free dnaGC GENOME CORP·Filed 2022·Application pending·0 cites
- 0654US2025131985A1Method for diagnosing cancer by using sequence frequency and size at each position of cell-free nucleic acid fragmentGC GENOME CORP·Filed 2022·Application pending·0 cites
- 0752US2024177806A1Deep learning based method for diagnosing and predicting cancer type using characteristics of cell-free nucleic acidGC GENOME CORP·Filed 2023·Application pending·0 cites
- 0850US12331364B2Method for diagnosing cancer and predicting type of cancer based on single nucleotide variant in cell-free DNAGC GENOME CORP·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 0948US2023028790A1Artificial intelligence-based chromosomal abnormality detection methodGC GENOME CORP·Filed 2020·Application pending·0 cites
- 1046US2024379229A1Cancer diagnosis and cancer-type prediction method based on cell-free dna and image analysis technologyGC GENOME CORP·Filed 2022·Application pending·0 cites
- 1145US2024233946A1Artificial intelligence-based method for early diagnosis of cancer, using cell-free dna distribution in tissue-specific regulatory regionGC GENOME CORP·Filed 2022·Application pending·0 cites
- 1242US2025037864A1Blood cell-free dna-based method for predicting prognosis of breast cancer treatmentGC GENOME CORP·Filed 2022·Application pending·0 cites
- 1340US2023383363A1Method for determining sensitivity to parp inhibitor or dna damaging agent using non-functional transcriptomeGC GENOME CORP·Filed 2021·Application pending·0 cites
- 1436US2024194294A1Artificial-intelligence-based method for detecting tumor-derived mutation of cell-free dna, and method for early diagnosis of cancer, using sameGC GENOME CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GC GENOME CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →